Krystal Biotech, Inc. (KRYS)
270.70
-1.91
(-0.70%)
USD |
NASDAQ |
Feb 10, 16:00
277.00
+6.30
(+2.33%)
After-Hours: 07:30
Krystal Biotech Total Assets (Quarterly) : 1.240B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 868.81M |
| DexCom, Inc. | 7.50B |
| Alkermes Plc | 2.330B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 102.22M |
| Shareholders Equity (Quarterly) | 1.138B |
| Debt to Equity Ratio | 0.0084 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | -0.01% |